Oxidants Produced by Methylglyoxal-modified Collagen Trigger ER Stress and Apoptosis in Skin Fibroblasts
Overview
Biology
General Medicine
Authors
Affiliations
Methylglyoxal (MG), a highly reactive dicarbonyl, interacts with proteins to form advanced glycation end products (AGEs). AGEs include a variety of compounds which were shown to have damaging potential and to accumulate in the course of different conditions such as diabetes mellitus and aging. After confirming collagen as a main target for MG modifications in vivo within the extracellular matrix, we show here that MG-collagen disrupts fibroblast redox homeostasis and induces endoplasmic reticulum (ER) stress and apoptosis. In particular, MG-collagen-induced apoptosis is associated with the activation of the PERK-eIF2α pathway and caspase-12. MG-collagen contributes to altered redox homeostasis by directly generating hydrogen peroxide and oxygen-derived free radicals. The induction of ER stress in human fibroblasts was confirmed using collagen extracts isolated from old mice in which MG-derived AGEs were enriched. In conclusion, MG-derived AGEs represent one factor contributing to diminished fibroblast function during aging.
Methylglyoxal Formation-Metabolic Routes and Consequences.
Vaskova J, Kovacova G, Pudelsky J, Palencar D, Mickova H Antioxidants (Basel). 2025; 14(2).
PMID: 40002398 PMC: 11852113. DOI: 10.3390/antiox14020212.
Methylglyoxal impairs human dermal fibroblast survival and migration by altering mRNA expression .
Prakoso N, Sundari A, Fadhilah , Abinawanto , Pustimbara A, Dwiranti A Toxicol Rep. 2024; 13:101835.
PMID: 39687678 PMC: 11646750. DOI: 10.1016/j.toxrep.2024.101835.
Coccini T, Caloni F, Russo L, Villani L, Lonati D, De Simone U Curr Res Toxicol. 2024; 7:100176.
PMID: 38975063 PMC: 11225170. DOI: 10.1016/j.crtox.2024.100176.
The cGAS-STING pathway: a therapeutic target in diabetes and its complications.
He W, Mu X, Wu X, Liu Y, Deng J, Liu Y Burns Trauma. 2024; 12:tkad050.
PMID: 38312740 PMC: 10838060. DOI: 10.1093/burnst/tkad050.
Liang D, Liu L, Zhao Y, Luo Z, He Y, Li Y Front Pharmacol. 2023; 14:1186712.
PMID: 37560476 PMC: 10407561. DOI: 10.3389/fphar.2023.1186712.